Morgan Stanley Call 310 PAYC 21.0.../ DE000MB6TXD5 /
03.05.2024 20:36:45 | Diff.- | Geld22:00:32 | Brief22:00:32 | Basiswert | Basispreis | Fälligkeit | Optionsart |
---|---|---|---|---|---|---|---|
0.167EUR | - | - Geld Vol: - |
- Brief Vol: - |
Paycom Software Inc | 310.00 - | 21.06.2024 | Call |
GlobeNewswire
13:03
Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National ...
GlobeNewswire
13:01
Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presente...
GlobeNewswire
13:00
BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024
GlobeNewswire
13:00
Edible Garden Reports Significant 27.6% Year-Over-Year Revenue Growth for First Quarter of 2024
GlobeNewswire
13:00
Dorman Products expands its catalog of cost-saving and aftermarket-exclusive repair solutions
GlobeNewswire
13:00
Plug to Revolutionize Middle-Mile Delivery with Class 6 Fuel Cell Electric Truck Integration
GlobeNewswire
13:00
Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
13:00
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results
GlobeNewswire
13:00
Boralex announces a substantial 62% increase in net earnings and continued disciplined development o...
GlobeNewswire
13:00
T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
13:00
TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the ...
GlobeNewswire
13:00
Creative Realities Inc. plans its expansion into EMEA and announces its beta launch to EMEA Integrat...
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite